<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title> &#187; pharmaceutical industry</title>
	<atom:link href="http://medicalconsumers.org/tag/pharmaceutical-industry/feed/" rel="self" type="application/rss+xml" />
	<link>http://medicalconsumers.org</link>
	<description></description>
	<lastBuildDate>Mon, 13 Feb 2012 23:20:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='medicalconsumers.org' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title> &#187; pharmaceutical industry</title>
		<link>http://medicalconsumers.org</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://medicalconsumers.org/osd.xml" title="" />
	<atom:link rel='hub' href='http://medicalconsumers.org/?pushpress=hub'/>
		<item>
		<title>WHO &amp; Pharma under fire over swine flu</title>
		<link>http://medicalconsumers.org/2010/04/02/who-pharma-draw-fire-over-swine-flu/</link>
		<comments>http://medicalconsumers.org/2010/04/02/who-pharma-draw-fire-over-swine-flu/#comments</comments>
		<pubDate>Fri, 02 Apr 2010 15:38:07 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Conflict of Interest]]></category>
		<category><![CDATA[influenza]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[faux pandemic]]></category>
		<category><![CDATA[flu]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[H1N1 deaths]]></category>
		<category><![CDATA[influenza threat]]></category>
		<category><![CDATA[PHARMA]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[tamiflu]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://medicalconsumers.org/?p=4829</guid>
		<description><![CDATA[Before the faux swine flu pandemic fades from memory, consider this: One country---Poland---made the decision not to knuckle under to the pharmaceutical industry and buy H1N1 swine flu vaccines for its citizens. Dr. Ewa Kopacz, who is Poland’s minister of health, refused to launch a national vaccination campaign for several good reasons, not the least of which was moderate nature of the H1N1 flu in the countries of the southern hemisphere.  But it was the “conditions of purchase” that sealed her refusal. She was told by the vaccine companies that only the government could purchase their products----vaccines would not be sold to clinics, or anyone in Poland. The price of each vaccine would be two to three times the cost of the yearly seasonal vaccine, though Dr. Kopacz knew the H1N1 vaccine is based on exactly the same technology.  What’s more, it was not known at the time whether people would need one or two vaccines for full protection. And most outrageous: the Polish government was expected to sign a contract, stating that anyone injured by a vaccine would be the government’s responsibility.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=4829&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2010/04/02/who-pharma-draw-fire-over-swine-flu/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
<enclosure url="http://coenews.coe.int/vod/100329_w01_w.wmv" length="0" type="video/asf" />
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Risks of Biologic Drugs</title>
		<link>http://medicalconsumers.org/2008/12/01/risks-of-biologic-drugs/</link>
		<comments>http://medicalconsumers.org/2008/12/01/risks-of-biologic-drugs/#comments</comments>
		<pubDate>Mon, 01 Dec 2008 19:51:12 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://medconsumers.wordpress.com/?p=1179</guid>
		<description><![CDATA[The fastest growing class of new drugs in the U.S. is the so-called biologics. Although the first in this class of drugs was approved in 1982, most have been marketed for a decade or less and little information was available about their safety.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=1179&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2008/12/01/risks-of-biologic-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Osteoporsis Drug: New Adverse Effects</title>
		<link>http://medicalconsumers.org/2008/08/01/osteoporsis-drug-new-adverse-effects/</link>
		<comments>http://medicalconsumers.org/2008/08/01/osteoporsis-drug-new-adverse-effects/#comments</comments>
		<pubDate>Fri, 01 Aug 2008 18:53:19 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bisphosphonates]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[marketing of osteoporosis]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://medconsumers.wordpress.com/?p=1158</guid>
		<description><![CDATA[An unusual type of severe fracture has been reported in people taking Fosamax for more than five years. Ironically, this drug is widely prescribed to prevent fractures in people with bone loss. The new finding came from a series of case reports published in the May/June Journal of Orthopaedic Trauma.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=1158&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2008/08/01/osteoporsis-drug-new-adverse-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Women-in-Towels Evista Ad Critiqued</title>
		<link>http://medicalconsumers.org/2008/07/01/women-in-towels-evista-ad-critiqued/</link>
		<comments>http://medicalconsumers.org/2008/07/01/women-in-towels-evista-ad-critiqued/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 19:06:48 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bisphosphonates]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Drug ads]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Evista]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://medconsumers.wordpress.com/?p=1165</guid>
		<description><![CDATA[The women in Eli Lilly’s new ad campaign are attractive, healthy-looking and wearing nothing but towels. “Cut two risks with Evista. The only agent indicated to treat osteoporosis and reduce the risk for invasive breast cancer.” That two-for-one claim for Evista makes it different from other drugs taken by symptom-free people.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=1165&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2008/07/01/women-in-towels-evista-ad-critiqued/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
		<item>
		<title>Chantix: Another FDA Failure?</title>
		<link>http://medicalconsumers.org/2008/06/01/chantix-another-fda-failure/</link>
		<comments>http://medicalconsumers.org/2008/06/01/chantix-another-fda-failure/#comments</comments>
		<pubDate>Sun, 01 Jun 2008 18:45:43 +0000</pubDate>
		<dc:creator>medconsumers</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[smoking]]></category>

		<guid isPermaLink="false">http://medconsumers.wordpress.com/?p=1154</guid>
		<description><![CDATA[For an inveterate FDA watcher like me it was an interesting spring. First, the agency's failure to police the safety of imported medical products became front-page news when it was revealed that batches of the blood-thinner heparin caused fatal allergic reactions because of contaminated ingredients imported from China. Coming on top of the lead-painted children’s toy and poisoned pet food episodes of a year earlier, the incident confirmed that the FDA lacked sufficient resources to carry out the requisite inspections of overseas manufacturers under its jurisdiction.<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=medicalconsumers.org&amp;blog=7088906&amp;post=1154&amp;subd=medconsumers&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://medicalconsumers.org/2008/06/01/chantix-another-fda-failure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">Maryann</media:title>
		</media:content>
	</item>
	</channel>
</rss>
